4//SEC Filing
Friedman Aviad 4
Accession 0001213900-22-000802
CIK 0001176309other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:30 PM ET
Size
11.1 KB
Accession
0001213900-22-000802
Insider Transaction Report
Form 4
Friedman Aviad
Director
Transactions
- Award
Common Stock
2022-01-03+6,000→ 6,000 total - Gift
Stock Option (right to buy
2022-01-03−10,000→ 0 totalExercise: $13.89Exp: 2032-01-03→ Common Stock (10,000 underlying) - Gift
Common Stock
2022-01-03−6,000→ 0 total - Award
Stock Option (right to buy
2022-01-03+10,000→ 10,000 totalExercise: $13.89Exp: 2032-01-03→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in 4 installments as follows: 1,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
- [F2]These shares of common stock and stock options were transferred, for no consideration, to a trust with an independent trustee.
- [F3]The Stock Option will vest in 4 installments as follows: 2,500 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026.
Documents
Issuer
ORAMED PHARMACEUTICALS INC.
CIK 0001176309
Entity typeother
Related Parties
1- filerCIK 0001683729
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:30 PM ET
- Size
- 11.1 KB